SFCL
CRSP icon

Strengthening Families & Communities LLC’s CRISPR Therapeutics CRSP Stock Holding History

Strengthening Families & Communities LLC’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27K Hold
60
– – ﹤0.01% 532
2026
Q1 		$2.85K Hold
60
– – ﹤0.01% 493
2025
Q4 		$3.15K Buy
+60
New +$3.59K ﹤0.01% 300
2022
Q4 		– Sell
-1
Closed – – 345
2022
Q3 		$0 Buy
+1
New +$72 ﹤0.01% 498

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Strengthening Families & Communities LLC's CRSP Position: Q2 2026 in Review

Strengthening Families & Communities LLC held its CRISPR Therapeutics (CRSP) position steady in Q2 2026 at 60 shares worth $3.27K. The position accounts for ﹤0.01% of the portfolio, ranked #532.

Strengthening Families & Communities LLC first reported a position in CRSP in Q3 2022 and has held it in 4 quarters since. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • Strengthening Families & Communities LLC held 60 shares of CRISPR Therapeutics worth $3.27K as of Q2 2026.
  • Strengthening Families & Communities LLC left its CRISPR Therapeutics share count unchanged in Q2 2026.
  • CRISPR Therapeutics made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #532 holding.
  • Strengthening Families & Communities LLC first reported a position in CRISPR Therapeutics in Q3 2022 and has held it in 4 quarters since.
  • 521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.